There are 140 resources available
27P - Concurrent chemoradiotherapy and immunotherapy for locally advanced cervical cancer: A cost-effectiveness analysis based on the KEYNOTE-A18 trial
Presenter: Hong Zhu
Session: Poster Display
28P - Real-life efficacy and safety of cemiplimab in advanced cervical cancer from a nominal use program in Italy: The MITO 44 study
Presenter: Valentina Tuninetti
Session: Poster Display
29P - fT3/fT4 ratio, systemic inflammation and skeletal muscle indexes in advanced cervical cancer (aCC) treated with cemiplimab in the MITO44 study
Presenter: Valentina Tuninetti
Session: Poster Display
30P - Cemiplimab in treatment of metastatic and recurrent cervical cancer
Presenter: Farrukh Djuraev
Session: Poster Display
32P - Cervical cancer: Barriers and smears to prevention
Presenter: Aiman Ibrahim
Session: Poster Display
33P - Impact of age in survival of Peruvian patients with cervical cancer
Presenter: Katia Mercedes Roque Perez
Session: Poster Display
50P - Vididencel, a cell-based cancer vaccine, induces tumor-directed immune responses in high-grade serous ovarian carcinoma patients
Presenter: Marco de Bruyn
Session: Poster Display
51P - Efficacy and safety by time to maintenance therapy treatment initiation in PRIMA/ENGOT-OV26/GOG-3012
Presenter: Noelle Cloven
Session: Poster Display
52P - MONITOR-UK: An initial analysis of a multi-centre, observational study of maintenance niraparib in ovarian cancer
Presenter: Shira Peleg Hasson
Session: Poster Display
53P - Description of BRCA mutated high-grade ovarian cancer demonstrating primary resistance to first-line platinum in the French national multicenter ESME database
Presenter: Alexandra Leary
Session: Poster Display